Acknowledgement
This research was supported by Korea Nazarene University Research Fund.
References
- Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, et al. The expression of cd70 and cd80 by gene-modified tumor cells induces an antitumor response depending on the mhc status. Cancer Gene Therapy. 2000. 7: 1543-1556. https://doi.org/10.1038/sj/cgt/7700268
- Eager R, Nemunaitis J. Gm-csf gene-transduced tumor vaccines. Molecular therapy: the Journal of the American Society of Gene Therapy. 2005. 12: 18-27. https://doi.org/10.1016/j.ymthe.2005.02.012
- Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines. 2019. 4: 7.
- Jin MZ, Wang XP. Immunogenic cell death-based cancer vaccines. Frontiers in Immunology. 2021. 12: 697964.
- Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al. Sipuleucel-t immunotherapy for castration-resistant prostate cancer. The New England Journal of Medicine. 2010. 363: 411-422. https://doi.org/10.1056/NEJMoa1001294
- Kim HS. Development of genetically modified tumor cell containing costimulatory molecule. Biomed Sci Letters. 2019. 25: 398-406. https://doi.org/10.15616/BSL.2019.25.4.398
- Kim HS. CD8-dependent tumor growth inhibition by tumor cells genetically modified with 4-1BBL. Biomed Sci Letters. 2021. 27: 329-333. https://doi.org/10.15616/BSL.2021.27.4.329
- Kim SK, Cho SW. The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment. Frontiers in Pharmacology. 2022. 13: 868695.
- Kooreman NG, Kim Y, de Almeida PE, Termglinchan V, Diecke S, Shao NY, et al. Autologous ipsc-based vaccines elicit antitumor responses in vivo. Cell Stem Cell. 2018. 22: 501-513 e507.
- Larocca C, Schlom J. Viral vector-based therapeutic cancer vaccines. Cancer Journal. 2011. 17: 359-371. https://doi.org/10.1097/ppo.0b013e3182325e63
- Lipson EJ, Sharfman WH, Chen S, McMiller TL, Pritchard TS, Salas JT, et al. Safety and immunologic correlates of melanoma gvax, a gm-csf secreting allogeneic melanoma cell vaccine administered in the adjuvant setting. Journal of Translational Medicine. 2015. 13: 214.
- Lopes A, Vandermeulen G, Preat V. Cancer DNA vaccines: Current preclinical and clinical developments and future perspectives. Journal of Experimental & Clinical Cancer Research. 2019. CR 38: 146.
- Munn DH, Bronte V. Immune suppressive mechanisms in the tumor microenvironment. Current Opinion in Immunology. 2016. 39: 1-6. https://doi.org/10.1016/j.coi.2015.10.009
- Rosenberg SA. Il-2: The first effective immunotherapy for human cancer. Journal of Immunology. 2014. 192: 5451-5458. https://doi.org/10.4049/jimmunol.1490019
- Sadeghi Najafabadi SA, Bolhassani A, Aghasadeghi MR. Tumor cell-based vaccine: An effective strategy for eradication of cancer cells. Immunotherapy. 2022. 14: 639-654. https://doi.org/10.2217/imt-2022-0036
- Santos PM, Butterfield LH. Dendritic cell-based cancer vaccines. Journal of Immunology. 2018. 200: 443-449. https://doi.org/10.4049/jimmunol.1701024
- Sartoris S, Mazzocco M, Tinelli M, Martini M, Mosna F, Lisi V, et al. Efficacy assessment of interferon-alpha-engineered mesenchymal stromal cells in a mouse plasmacytoma model. Stem Cells and Development. 2011. 20: 709-719.
- Schneble E, Clifton GT, Hale DF, Peoples GE. Peptide-based cancer vaccine strategies and clinical results. Methods in Molecular Biology. 2016. 1403: 797-817. https://doi.org/10.1007/978-1-4939-3387-7_46
- Srivatsan S, Patel JM, Bozeman EN, Imasuen IE, He S, Daniels D, et al. Allogeneic tumor cell vaccines: The promise and limitations in clinical trials. Human Vaccines & Immuno-therapeutics. 2014. 10: 52-63. https://doi.org/10.4161/hv.26568
- Tang T, Huang X, Zhang G, Hong Z, Bai X, Liang T. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduction and Targeted Therapy. 2021. 6: 72.
- Ullrich E, Bonmort M, Mignot G, Kroemer G, Zitvogel L. Tumor stress, cell death and the ensuing immune response. Cell Death and Differentiation. 2008. 15: 21-28. https://doi.org/10.1038/sj.cdd.4402266
- Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, et al. Immune evasion in cancer: Mechanistic basis and therapeutic strategies. Seminars in Cancer Biology. 2015. 35 Suppl: S185-S198. https://doi.org/10.1016/j.semcancer.2015.03.004